Despite Lower Earnings Than Five Years Ago, Labcorp Holdings (NYSE:LH) Investors Are up 65% Since Then
Despite Lower Earnings Than Five Years Ago, Labcorp Holdings (NYSE:LH) Investors Are up 65% Since Then
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you'd generally like to see the share price rise faster than the market. But Labcorp Holdings Inc. (NYSE:LH) has fallen short of that second goal, with a share price rise of 37% over five years, which is below the market return. Looking at the last year alone, the stock is up 12%.
當您買入並持有股票以長期投資時,您肯定希望其能獲得正收益。此外,您通常希望看到股價上漲速度超過市場。但Labcorp Holdings Inc.(紐交所:LH)未能達到第二個目標,股價在五年內上漲了37%,低於市場回報。僅看過去一年,該股上漲了12%。
In light of the stock dropping 3.4% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive five-year return.
考慮到股票在過去一週內下跌了3.4%,我們想調查更長期的情況,並查看公司的五年回報率是否是基本面的推動因素。
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
引用本傑明·格雷厄姆的話:在短期內,市場是投票機,但在長期內,市場是稱重機。通過比較每股收益(EPS)和股票價格的時間變化,我們可以感受到投資者對公司的態度隨時間而變化。
During five years of share price growth, Labcorp Holdings actually saw its EPS drop 7.4% per year.
在股價增長的五年中,Labcorp Holdings 實際上看到其每股收益下降了7.4%。
This means it's unlikely the market is judging the company based on earnings growth. Because earnings per share don't seem to match up with the share price, we'll take a look at other metrics instead.
這意味着市場不太可能是根據盈利增長來評判公司的。因爲每股收益似乎與股價不匹配,我們將轉而關注其他指標。
The modest 1.2% dividend yield is unlikely to be propping up the share price. It is not great to see that revenue has dropped by 0.6% per year over five years. It certainly surprises us that the share price is up, but perhaps a closer examination of the data will yield answers.
這個不起眼的1.2%的分紅派息率不太可能支撐股價。在過去五年中,營業收入下降了0.6%每年並不樂觀。股價上漲確實讓我們感到意外,但也許仔細檢查數據將會得出答案。
You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).
您可以看到以下收益和營收的變化情況(通過單擊圖像了解精確值)。
Labcorp Holdings is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. So we recommend checking out this free report showing consensus forecasts
Labcorp Holdings是一個知名股票,有很多分析師關注,表明對未來增長有一定的可見度。因此,我們建議查看這份免費報告,其中顯示了共識預測。
What About Dividends?
關於分紅派息的問題
When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Labcorp Holdings, it has a TSR of 65% for the last 5 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!
在考慮投資回報時,重要的是要考慮總股東回報(TSR)和股價回報之間的差異。股價回報只反映了股價的變化,而TSR包括了股息的價值(假設它們已被再投資)和任何折價資本籌集或分拆的收益。可以說TSR爲支付股息的股票提供了更全面的圖景。就Labcorp Holdings而言,過去5年的TSR爲65%,超過了我們先前提到的股價回報。毫無疑問,股息支付很大程度上解釋了這種差異!
A Different Perspective
另一種看法
Labcorp Holdings shareholders gained a total return of 14% during the year. But that return falls short of the market. The silver lining is that the gain was actually better than the average annual return of 10% per year over five year. This suggests the company might be improving over time. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Labcorp Holdings , and understanding them should be part of your investment process.
Labcorp Holdings股東在這一年中獲得了總回報率達到了14%。但這一回報率低於市場。值得注意的是,這一收益實際上比過去五年年均10%的回報率要好。這表明公司可能會隨着時間的推移而改善。我發現長期關注股價是業務績效的代理很有趣。但爲了真正獲得洞察,我們也需要考慮其他信息。例如,要考慮投資風險的常態。我們已經發現了Labcorp Holdings的兩個警示信號,理解它們應該成爲您投資過程的一部分。
We will like Labcorp Holdings better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.
如果我們看到一些大規模內部買入,我們會更喜歡Labcorp Holdings。在等待時,請查看這份免費的被低估股票名單(主要是小市值股票),這些股票最近有相當大規模的內部買入。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。
譯文內容由第三人軟體翻譯。